Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention

Overview of attention for article published in Stem Cell Research & Therapy, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 25,504 followers.

RT @UCLAstemcell: Scientists from @UCLA @UCLAstemcell have found the development of blood stem cell-engineered iNKT cells to be a promising…

31 Mar 2022

Reply Repost Favourite

Scientists from @UCLA @UCLAstemcell have found the development of blood stem cell-engineered iNKT cells to be a promising off-the-shelf cell product for treating COVID-19. (via @BioMedCentral) https://t.co/gHKqAuOkwv

31 Mar 2022

Reply Repost Favourite

RT @Cord_Blood_News: A team at @UciStemCell, including Dr. Lili Yang, present on the development of off-the-shelf #hematopoietic stem cell-…

30 Mar 2022

Reply Repost Favourite

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention https://t.co/0phKyieIBl

29 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.